Autonomix Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Net Income	-16.72	-11.41	-15.43	-1.99
Depreciation & Amortization	0.01	0.18	0.08	-
Stock-Based Compensation	4.26	1.63	0.62	-
Other Adjustments	0.27	0.1	8	-
Changes in Accounts Payable	0.02	0.18	0.32	0.08
Changes in Accrued Expenses	-0.03	0.75	0.24	0.05
Changes in Other Operating Activities	-0.1	0.31	-0.48	0.01
Operating Cash Flow	-12.28	-8.26	-6.65	-1.85
Operating Cash Flow Growth	-	-	-	-
Capital Expenditures	-0.01	-0.01	-0.02	-
Investing Cash Flow	-0.01	-0.01	-0.02	-
Long-Term Debt Issued	-	-	2	-
Net Long-Term Debt Issued (Repaid)	-	-	2	-
Issuance of Common Stock	10.59	10.03	13.71	0.68
Net Common Stock Issued (Repurchased)	10.59	10.03	13.71	0.68
Other Financing Activities	-0.43	-1.23	-1.3	-
Financing Cash Flow	10.16	8.8	14.41	0.68
Net Cash Flow	-2.13	0.53	7.74	-1.18
Free Cash Flow	-12.29	-8.27	-6.67	-1.85
Free Cash Flow Growth	-	-	-	-
Free Cash Flow Per Share	-35.77	-98.34	-134.53	-64.76
Levered Free Cash Flow	-16.82	-10	-13.29	-1.85
Unlevered Free Cash Flow	-17.14	-10.18	-11.89	-1.85

SEC Filings: 10-K · 10-Q